The University of Chicago Header Logo

Connection

John Fung to Rats, Inbred Lew

This is a "connection" page, showing publications John Fung has written about Rats, Inbred Lew.
Connection Strength

0.724
  1. A new xenogeneic radiation chimera (hamster-to-rat). Transplantation. 1994 May 27; 57(10):1528-32.
    View in: PubMed
    Score: 0.117
  2. Preservation injury and acute rejection of rat intestinal grafts: protection afforded by pyruvate. J Gastrointest Surg. 1999 Sep-Oct; 3(5):549-54.
    View in: PubMed
    Score: 0.042
  3. FK 506 prolongs survival of liver but not heart mouse-to-rat vascularized xenografts. Transplant Proc. 1994 Jun; 26(3):1211.
    View in: PubMed
    Score: 0.029
  4. Cytokine messenger RNA profiles in hamster-to-rat liver xenografts. Transplant Proc. 1993 Feb; 25(1 Pt 1):444-5.
    View in: PubMed
    Score: 0.027
  5. The induction of pseudo-graft-versus-host disease following syngeneic bone marrow transplantation using FK 506. Transplant Proc. 1991 Dec; 23(6):3234-5.
    View in: PubMed
    Score: 0.025
  6. Prolonged prevention of acute graft-versus-host disease after allogeneic bone marrow transplantation by donor pretreatment using FK 506. Transplant Proc. 1991 Dec; 23(6):3238-9.
    View in: PubMed
    Score: 0.025
  7. The effect of thymus transplantation on allograft rejection in thymectomized bone marrow chimeras. Transplant Proc. 1990 Dec; 22(6):2536-8.
    View in: PubMed
    Score: 0.023
  8. Portacaval shunt causes apoptosis and liver atrophy in rats despite increases in endogenous levels of major hepatic growth factors. J Hepatol. 2002 Sep; 37(3):340-8.
    View in: PubMed
    Score: 0.013
  9. Activation of the lipopolysaccharide signaling pathway in hepatic transplantation preservation injury. Transplantation. 2002 Jul 15; 74(1):7-13.
    View in: PubMed
    Score: 0.013
  10. Hamster-to-rat bone marrow xenotransplantation and humoral graft vs. host disease. Xenotransplantation. 2001 Aug; 8(3):213-21.
    View in: PubMed
    Score: 0.012
  11. Immune complex disease in immunosuppressed rat recipients of hamster liver xenografts. Transplant Proc. 2001 Feb-Mar; 33(1-2):778.
    View in: PubMed
    Score: 0.012
  12. Evidence of microchimerism after pretransplant blood transfusion and FK 506 in liver xenograft. Transplant Proc. 2000 Dec; 32(8):2710-2.
    View in: PubMed
    Score: 0.012
  13. Administration of CTLA4-Ig enhances the incidence of hamster-to-rat xenogeneic bone marrow engraftment and alters the presentation of graft-vs-host disease. Transplant Proc. 2000 Aug; 32(5):1032-3.
    View in: PubMed
    Score: 0.011
  14. Xenogeneic humoral graft-Vs-host disease following hamster-to-Rat bone marrow transplantation. Transplant Proc. 2000 Aug; 32(5):1036-7.
    View in: PubMed
    Score: 0.011
  15. Concordant hamster-to-rat liver xenotransplantation leads to hyperlipidemia. Transplant Proc. 2000 Aug; 32(5):1109.
    View in: PubMed
    Score: 0.011
  16. Loss of serum bicarbonate after discordant liver xenotransplantation. Transplant Proc. 2000 Aug; 32(5):1110.
    View in: PubMed
    Score: 0.011
  17. Serum protein immunogenicity: implications for liver xenografting. Electrophoresis. 2000 Mar; 21(5):965-75.
    View in: PubMed
    Score: 0.011
  18. Role of UW solution and sodium nitroprusside in reperfusion of liver xenografts from guinea-pig to rat. Xenotransplantation. 1999 May; 6(2):117-22.
    View in: PubMed
    Score: 0.010
  19. Prolonged survival of islet allografts following combined therapy with tacrolimus and leflunomide. Transplant Proc. 1999 Feb-Mar; 31(1-2):646-7.
    View in: PubMed
    Score: 0.010
  20. Pyruvate inhibits the chronic damage which ensues after ischemia/reperfusion injury of kidneys. Transplant Proc. 1999 Feb-Mar; 31(1-2):1033.
    View in: PubMed
    Score: 0.010
  21. Adenovirus-mediated gene transfer to liver grafts: an improved method to maximize infectivity. Transplantation. 1998 Dec 15; 66(11):1545-51.
    View in: PubMed
    Score: 0.010
  22. Tacrolimus enhances the immunosuppressive effect of cyclophosphamide but not that of leflunomide or mycophenolate mofetil in a model of discordant liver xenotransplantation. Transplant Proc. 1998 Jun; 30(4):1091-2.
    View in: PubMed
    Score: 0.010
  23. Early recipient-donor switch of the complement type after liver xenotransplantation. Immunol Invest. 1997 Aug-Dec; 26(5-7):589-600.
    View in: PubMed
    Score: 0.009
  24. Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption. Am J Pathol. 1997 Feb; 150(2):563-78.
    View in: PubMed
    Score: 0.009
  25. Experimental animal model of graft-versus-host disease (GVHD) after small-bowel transplantation: characteristics of the model and application to developing treatment strategies. Transplant Proc. 1997 Feb-Mar; 29(1-2):700.
    View in: PubMed
    Score: 0.009
  26. Donor-specific transfusion in the nude rat prolongs survival of subsequently transplanted hamster cardiac xenografts. Transplant Proc. 1997 Feb-Mar; 29(1-2):928-9.
    View in: PubMed
    Score: 0.009
  27. Cytokine profile in graft-versus-host disease after small bowel transplantation. Transplant Proc. 1996 Oct; 28(5):2455.
    View in: PubMed
    Score: 0.009
  28. Tacrolimus pretreatment attenuates preexisting xenospecific immunity and abrogates hyperacute rejection in a presensitized hamster to rat liver transplant model. Transplantation. 1996 Jun 27; 61(12):1730-5.
    View in: PubMed
    Score: 0.008
  29. The antigenicity of serum proteins and their role in xenograft rejection. Transplant Proc. 1996 Apr; 28(2):669-70.
    View in: PubMed
    Score: 0.008
  30. Pretreatment of recipients (nude rat) with donor antigens leads to prolonged survival of hamster heart xenografts. Transplant Proc. 1996 Apr; 28(2):696-7.
    View in: PubMed
    Score: 0.008
  31. Use of MHC class I or II "knock out" mice to delineate the role of these molecules in acceptance/rejection of xenografts. Transplant Proc. 1996 Apr; 28(2):732.
    View in: PubMed
    Score: 0.008
  32. Prolonged survival of hearts obtained from chimeric donors in a mouse to rat xenotransplant model. Transplant Proc. 1996 Apr; 28(2):733-4.
    View in: PubMed
    Score: 0.008
  33. Effect of tacrolimus and splenectomy on engraftment and GVHD after bone marrow xenotransplantation in the reciprocal hamster to rat animal models. Transplant Proc. 1996 Apr; 28(2):736-7.
    View in: PubMed
    Score: 0.008
  34. Perioperative treatment with phosphatidic acid inhibitor (Lisofylline leads to prolonged survival of hearts in the guinea pig to rat xenotransplant model. Transplant Proc. 1996 Apr; 28(2):738-9.
    View in: PubMed
    Score: 0.008
  35. Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation. 1995 Jul 27; 60(2):158-71.
    View in: PubMed
    Score: 0.008
  36. Mechanisms of protection from humoral rejection by a xenografted liver. Transplant Proc. 1995 Feb; 27(1):300-2.
    View in: PubMed
    Score: 0.008
  37. The protection from humoral rejection given by a liver xenograft is species-specific and non-MHC restricted. Transplant Proc. 1995 Feb; 27(1):270.
    View in: PubMed
    Score: 0.008
  38. A simplified method for growing dendritic cells from rat bone marrow. Adv Exp Med Biol. 1995; 378:53-5.
    View in: PubMed
    Score: 0.008
  39. Interferon-gamma induced expression of MHC antigens facilitates identification of donor cells in chimeric transplant recipients. Cell Transplant. 1994 Jul-Aug; 3(4):345-8.
    View in: PubMed
    Score: 0.007
  40. Pretransplant xenogeneic blood transfusion combined with FK 506 prolongs hamster-to-rat liver xenograft survival. Transplant Proc. 1994 Jun; 26(3):1208.
    View in: PubMed
    Score: 0.007
  41. Complement and target cells belong to the same species after liver xenografting: protection from hyperacute rejection. Transplant Proc. 1994 Jun; 26(3):1255.
    View in: PubMed
    Score: 0.007
  42. Donor species complement after liver xenotransplantation. The mechanism of protection from hyperacute rejection. Transplantation. 1994 Mar 27; 57(6):918-22.
    View in: PubMed
    Score: 0.007
  43. Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. Transplant Proc. 1993 Dec; 25(6):3337-44.
    View in: PubMed
    Score: 0.007
  44. Cytidine potentiates the inhibitory effect of brequinar sodium on xeno-MLR, antibody production, and concordant hamster to rat cardiac xenograft survival. Ann N Y Acad Sci. 1993 Nov 30; 696:227-34.
    View in: PubMed
    Score: 0.007
  45. Dendritic cell replacement in long-surviving liver and cardiac xenografts. Transplantation. 1993 Aug; 56(2):482-4.
    View in: PubMed
    Score: 0.007
  46. Hamster coagulation and serum proteins in rat recipients of hamster xenografts. Transplantation. 1993 Aug; 56(2):489-90.
    View in: PubMed
    Score: 0.007
  47. Induction of donor-specific transplantation tolerance to skin and cardiac allografts using mixed chimerism in (A + B-->A) in rats. Cell Transplant. 1993 Jul-Aug; 2(4):345-53.
    View in: PubMed
    Score: 0.007
  48. Liver allograft rejection in sensitized recipients. Observations in a clinically relevant small animal model. Am J Pathol. 1993 May; 142(5):1383-91.
    View in: PubMed
    Score: 0.007
  49. Successful hamster-to-rat liver xenotransplantation under FK506 immunosuppression induces unresponsiveness to hamster heart and skin. Transplantation. 1993 Mar; 55(3):659-61.
    View in: PubMed
    Score: 0.007
  50. Hamster-to-rat liver xenografts protect extrahepatic organs from rejection. Transplant Proc. 1993 Feb; 25(1 Pt 1):414-5.
    View in: PubMed
    Score: 0.007
  51. Long-term survival of heart and liver xenografts with splenectomy and FK 506. Transplant Proc. 1993 Feb; 25(1 Pt 1):647-8.
    View in: PubMed
    Score: 0.007
  52. Comparison of the small intestine after multivisceral transplantation with the small intestines transplanted with portal or caval drainage. Transplant Proc. 1992 Jun; 24(3):1143-4.
    View in: PubMed
    Score: 0.006
  53. Effect of FK 506 on FK-binding protein and transforming growth factor beta gene expression. Transplant Proc. 1991 Dec; 23(6):2873-4.
    View in: PubMed
    Score: 0.006
  54. The effect of cyclosporine, rapamycin and FK 506 the survival following allogeneic bone marrow transplantation. Transplant Proc. 1991 Dec; 23(6):3232-3.
    View in: PubMed
    Score: 0.006
  55. Differential survival of hamster-to-rat liver and cardiac xenografts under FK 506 immunosuppression. Transplant Proc. 1991 Dec; 23(6):3269-71.
    View in: PubMed
    Score: 0.006
  56. Prevention of graft-versus-host disease following allogeneic bone marrow transplantation in rats using FK506. Transplantation. 1991 Oct; 52(4):590-4.
    View in: PubMed
    Score: 0.006
  57. FK 506 reverses acute graft-versus-host disease after allogeneic bone marrow transplantation in rats. Surgery. 1991 Aug; 110(2):357-63; discussion 363-4.
    View in: PubMed
    Score: 0.006
  58. Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery. 1990 Nov; 108(5):880-9.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.